机译:Exposure‐response relationships for the efficacy and safety of filgotinib and its metabolite GS‐829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies
Gilead Sciences Inc;
Certara Inc;
drug safety; PK‐PD; randomized controlled trial; rheumatoid arthritis; therapeutics; Specialties: filgotinib; JAK inhibitors; exposure‐response;